Peripheral Vascular Devices Market to Reach USD 16.90 Billion by 2033, Growing at 5.3% CAGR; North America Leads with 41% Share; Key Players: Medtronic, Abbott, Boston Scientific

The Global Peripheral Vascular Devices Market was valued at USD 10.44 billion in 2024 and is expected to reach USD 16.90 billion by 2033, growing at a CAGR of 5.3 percent during the forecast period. Peripheral vascular devices include stents, angioplasty balloons, catheters, atherectomy devices, vascular grafts and other tools used to treat blockages and disorders in blood vessels outside the heart and brain. Market growth is driven by the rising prevalence of peripheral arterial disease, increasing cases of diabetes and hypertension, an aging population and the growing demand for minimally invasive vascular procedures that reduce recovery time and hospital stays.

Technology developments such as drug-eluting stents, advanced atherectomy systems and improved imaging-guided techniques are further supporting market expansion. Hospitals remain the leading end-use segment, while outpatient and ambulatory surgical centres are gaining traction as endovascular procedures become more common. North America holds the largest share due to well-established healthcare systems and high treatment rates, while Asia Pacific is emerging as a fast-growing region due to rising vascular disease incidence, improving healthcare infrastructure and increasing adoption of endovascular treatments.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/peripheral-vascular-devices-market?sai-v

The Peripheral Vascular Devices Market advances minimally invasive vascular care with cutting-edge tools that restore blood flow, treat blockages, and improve cardiovascular outcomes.

Key Developments

United States

✅ October 2025: U.S. medical device manufacturers expanded use of advanced intravascular imaging technologies (IVUS/OCT) to improve precision in peripheral angioplasty and stent placement.

✅ August 2025: American hospitals increased adoption of intravascular lithotripsy (IVL) systems for treating heavily calcified peripheral arterial lesions, improving procedural success rates.

✅ May 2025: U.S. vascular care providers introduced next-generation drug-eluting peripheral stents with enhanced anti-restenosis coatings for long-segment PAD treatments.

Japan

✅ September 2025: Japanese device companies launched ultra-flexible peripheral guidewires designed for complex below-the-knee interventions and chronic total occlusions.

✅ June 2025: Japan's interventional cardiology sector adopted new low-profile angioplasty balloon catheters engineered for improved crossability in small and tortuous vessels.

✅ March 2025: Japanese research institutions developed bioabsorbable scaffold platforms aimed at next-generation peripheral vascular repair solutions.

Mergers & Acquisitions

United States

✅ July 2025: A major U.S. vascular device manufacturer acquired a peripheral intervention startup specializing in advanced crossing and micro-catheter technologies to strengthen its PAD portfolio.

Japan

✅ February 2025: A Japanese medical device company partnered with a domestic imaging-technology provider to co-develop high-clarity OCT/IVUS systems for peripheral vascular procedures.

✅ January 2025: A Japan-based endovascular solutions manufacturer formed a strategic alliance with a U.S. robotics firm to integrate robotic-assisted navigation into peripheral intervention platforms.

Key Players
Abbott Laboratories | Boston Scientific Corporation | Becton, Dickinson and Company (BD) | Cook Medical | Cordis Corporation | Edwards Lifesciences | MicroPort | Terumo Corporation | Medtronic | Volcano Corporation

Key Highlights
• Abbott Laboratories - Holds 14.8% share of the global cardiovascular and interventional device market, driven by strong sales of stents, vascular closure devices, and structural heart solutions like MitraClip.

• Boston Scientific Corporation - Accounts for 13.6% market share, supported by its broad interventional cardiology portfolio, including drug-eluting stents, atherectomy devices, and electrophysiology systems.

• Becton, Dickinson and Company (BD) - Maintains 7.9% share, recognized for its minimally invasive surgical instruments, biopsy systems, and peripheral intervention devices.

• Cook Medical - Holds 6.4% share, driven by its specialty in vascular intervention devices, embolization solutions, and aortic therapy systems.

• Cordis Corporation - Represents 5.8% share, with strong presence in interventional vascular devices and coronary stent technologies.

• Edwards Lifesciences - Accounts for 10.1% share, led by its global leadership in structural heart devices, especially transcatheter heart valves (TAVR).

• MicroPort - Maintains 4.9% share, supported by strong adoption of its coronary stents and growing penetration in emerging markets.

• Terumo Corporation - Holds 8.7% share, driven by its guidewires, catheters, access devices, and advanced interventional solutions used globally.

• Medtronic - Leads with 18.3% market share, supported by its extensive cardiovascular device portfolio including stents, catheters, heart valves, and endovascular repair systems.

• Volcano Corporation - Represents 4.0% share, known for its intravascular ultrasound (IVUS) and fractional flow reserve (FFR) technologies widely used in coronary diagnostics.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peripheral-vascular-devices-market?sai-v

Market Drivers

• Rising prevalence of peripheral artery disease (PAD), deep vein thrombosis (DVT), and other vascular disorders due to aging populations and lifestyle-related risk factors.

• Growing demand for minimally invasive vascular procedures such as angioplasty, atherectomy, and stent placements.

• Increasing adoption of advanced peripheral stents, drug-coated balloons, and vascular closure devices for improved treatment outcomes.

• Rising incidence of diabetes and obesity contributing to higher vascular complications and the need for interventional treatments.

• Technological advancements including self-expanding stents, biodegradable implants, and image-guided vascular intervention systems.

• Expanding use of peripheral vascular devices in ambulatory surgical centers and outpatient care settings.

• Growing awareness and early diagnosis of vascular diseases through screening programs and improved clinical guidelines.

Industry Developments

• Introduction of next-generation drug-eluting and bioresorbable vascular stents for enhanced vessel healing and long-term performance.

• Launch of advanced atherectomy systems designed to remove plaque with higher precision and reduced vessel trauma.

• Expansion of drug-coated balloon (DCB) portfolios targeting peripheral artery disease in femoropopliteal and below-the-knee segments.

• Increasing FDA and CE approvals for innovative peripheral vascular devices with improved safety and efficacy profiles.

• Collaborations between medical device companies and hospitals to develop customized vascular treatment solutions.

• Adoption of AI-enabled vascular imaging technologies to support real-time decision-making in interventional procedures.

• Growing investment in hybrid operating rooms supporting complex peripheral vascular interventions.

Regional Insights

• North America - 41% driven by "high prevalence of vascular diseases, strong interventional cardiology infrastructure, and rapid adoption of advanced peripheral devices."

• Europe - 30% supported by "growing geriatric population, increasing PAD treatment volumes, and rising adoption of minimally invasive vascular procedures."

• Asia Pacific - 22% fueled by "rising diabetes burden, improving access to vascular care, and increasing investments in modern cardiovascular treatment facilities."

• Latin America - 5% driven by "growing incidence of vascular disorders and expanding availability of advanced interventional devices."

• Middle East & Africa - 2% supported by "improving healthcare infrastructure and increasing adoption of modern vascular treatment technologies."

Key Segments:
➥ By Type
Functional peripheral artery disease refers to conditions where arterial blood flow is impaired due to spasms or temporary narrowing rather than structural blockage. Organic peripheral artery disease involves permanent arterial changes such as plaque buildup, atherosclerosis, or vessel wall thickening, making it the more clinically significant and widely diagnosed form.

➥ By Device Type
Vascular stents are commonly used to keep narrowed arteries open and restore proper blood flow. Balloon catheters help dilate blocked or restricted arteries through angioplasty procedures. Guidewires support catheter placement and navigation during minimally invasive interventions. Atherectomy devices remove plaque buildup mechanically to restore arterial lumen. Inferior vena cava (IVC) filters prevent blood clots from reaching the lungs in high-risk patients. Embolic protection devices safeguard against debris during vascular interventions. Others include imaging catheters, vascular grafts, and closure devices used across PAD treatment procedures.

➥ By End-User
Hospitals remain the primary end-users due to high procedure volumes and availability of advanced vascular treatment facilities. Specialty clinics increasingly adopt minimally invasive PAD devices for outpatient interventions. Ambulatory surgical centers (ASCs) support cost-effective, same-day vascular procedures. Academic research centers contribute to device innovation, clinical trials, and advanced PAD research. Others include diagnostic centers and integrated healthcare networks offering vascular care.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/peripheral-vascular-devices-market?sai-v

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.